Search Results

There are 12262 results for: content related to: Drug selection and timing of initiation of treatment in early Parkinson's disease

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Article first published online : 12 JUN 2015, DOI: 10.1002/mds.26295

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Article first published online : 19 JUN 2012, DOI: 10.1002/mds.25051

  3. Improving l-dopa therapy: The development of enzyme inhibitors

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 103–113, Oscar S. Gershanik

    Article first published online : 21 OCT 2014, DOI: 10.1002/mds.26050

  4. You have free access to this content
    Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat

    British Journal of Pharmacology

    Volume 149, Issue 6, November 2006, Pages: 647–656, J P M Finberg, A Gross, O Bar-Am, R Friedman, Y Loboda and M B H Youdim

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706908

  5. Evidence-based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004

    Movement Disorders

    Volume 20, Issue 5, May 2005, Pages: 523–539, Christopher G. Goetz, Werner Poewe, Olivier Rascol and Cristina Sampaio

    Article first published online : 7 APR 2005, DOI: 10.1002/mds.20464

  6. 2nd World Parkinson Congress Abstracts

    Movement Disorders

    Volume 25, Issue S3, 15 September 2010, Pages: S569–S717,

    Article first published online : 9 SEP 2010, DOI: 10.1002/mds.23386

    Corrected by:

    Erratum: Erratum

    Vol. 25, Issue 15, 2694, Article first published online: 10 NOV 2010

  7. Neuroprotection in Parkinson's disease: Clinical trials

    Annals of Neurology

    Volume 53, Issue S3, 2003, Pages: S87–S99, Fabrizio Stocchi and C. Warren Olanow

    Article first published online : 24 MAR 2003, DOI: 10.1002/ana.10488

  8. Limitations of current Parkinson's disease therapy

    Annals of Neurology

    Volume 53, Issue S3, 2003, Pages: S3–S15, Olivier Rascol, Pierre Payoux, Fabienne Ory, Joaquim J. Ferreira, Christine Brefel-Courbon and Jean-Louis Montastruc

    Article first published online : 24 MAR 2003, DOI: 10.1002/ana.10513

  9. Other pharmacological treatments for motor complications and dyskinesias

    Movement Disorders

    Volume 20, Issue S11, May 2005, Pages: S38–S44, Cheryl Waters

    Article first published online : 8 APR 2005, DOI: 10.1002/mds.20462

  10. You have free access to this content
    Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

    British Journal of Pharmacology

    Volume 164, Issue 4, October 2011, Pages: 1357–1391, Susan Duty and Peter Jenner

    Article first published online : 26 SEP 2011, DOI: 10.1111/j.1476-5381.2011.01426.x

  11. Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study

    Movement Disorders

    Volume 21, Issue 3, March 2006, Pages: 343–353, Wolfgang H. Oertel, Erik Wolters, Cristina Sampaio, Santiago Gimenez-Roldan, Bruno Bergamasco, Max Dujardin, Donald G. Grosset, Guy Arnold, Klaus L. Leenders, Hans-Peter Hundemer, Alberto Lledó, Andrew Wood, Paul Frewer and Johannes Schwarz

    Article first published online : 6 OCT 2005, DOI: 10.1002/mds.20724

  12. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Article first published online : 6 JUN 2014, DOI: 10.1002/mds.25914

  13. Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: A 3-month, randomized, placebo-controlled study

    Movement Disorders

    Volume 19, Issue 4, April 2004, Pages: 426–432, Cheryl H. Waters, Kapil D. Sethi, Robert A. Hauser, Eric Molho and John M. Bertoni

    Article first published online : 10 FEB 2004, DOI: 10.1002/mds.20036

  14. Parkinsonism Treatment

    Standard Article

    Ullmann's Encyclopedia of Industrial Chemistry

    Jana Hennemann, Wolfgang Schatton and Ralf H. Lyssy

    Published Online : 15 JUL 2008, DOI: 10.1002/14356007.a19_001.pub2

  15. Parkinson's Disease

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt084

  16. Medical treatment of freezing of gait

    Movement Disorders

    Volume 23, Issue S2, 2008, Pages: S482–S488, Nir Giladi

    Article first published online : 30 JUL 2008, DOI: 10.1002/mds.21914

  17. Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease

    Movement Disorders

    Volume 25, Issue 7, 15 May 2010, Pages: 858–866, Ray L. Watts, Kelly E. Lyons, Rajesh Pahwa, Kapil Sethi, Matthew Stern, Robert A. Hauser, Warren Olanow, Alex M. Gray, Bryan Adams, Nancy L. Earl and On Behalf of the 228 Study Investigators

    Article first published online : 13 APR 2010, DOI: 10.1002/mds.22890

  18. You have free access to this content
    Therapeutic and Diagnostic Agents for Parkinson's Disease

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    Raymond G. Booth, John L. Neumeyer and Ross J. Baldessarini

    Published Online : 15 SEP 2010, DOI: 10.1002/0471266949.bmc105.pub2

  19. Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naïve primates

    Movement Disorders

    Volume 20, Issue 3, March 2005, Pages: 306–314, Lance A. Smith, Michael J. Jackson, Ghassan Al-Barghouthy, Sarah Rose, Mikko Kuoppamaki, Warren Olanow and Peter Jenner

    Article first published online : 15 OCT 2004, DOI: 10.1002/mds.20317

  20. You have free access to this content
    Patient Diaries As a Clinical Endpoint in Parkinson's Disease Clinical Trials

    CNS Neuroscience & Therapeutics

    Volume 18, Issue 5, May 2012, Pages: 380–387, Spyridon (Spyros) Papapetropoulos

    Article first published online : 7 JUN 2011, DOI: 10.1111/j.1755-5949.2011.00253.x